Focus on Lower Risk of Tardive Dyskinesia with Atypical Antipsychotics

Author： Nasrallah Henry  

Publisher： Informa Healthcare

ISSN： 1040-1237

Source： Annals of Clinical Psychiatry (after Jan 1, 2004), Vol.18, Iss.1, 2006-01, pp. : 57-62

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The effect of atypical versus typical antipsychotics on tardive dyskinesia: A naturalistic study

By Leon Jose  

European Archives of Psychiatry and Clinical Neuroscience, Vol. 257, Iss. 3, 2007-04 ,pp. : 169-172

Springer Publishing Company

Access to resources Recommend Favorite

Affective symptomatology in schizophrenia: a risk factor for tardive dyskinesia?

By Schulze T.G.   Muller D.J.   Krauss H.   Marwinski K.   Maroldt A.-O.   Novo y Fernandez A.   Fimmers R.   Held T.   Maier W.   Nothen M.M.   Rietschel M.  

European Psychiatry, Vol. 16, Iss. 1, 2001-02 ,pp. : 71-74

Elsevier

Access to resources Recommend Favorite

Treatment of non-schizophrenic disorders: focus on atypical antipsychotics

By Jeste D.V.   Dolder C.R.  

Journal of Psychiatric Research, Vol. 38, Iss. 1, 2004-01 ,pp. : 73-103

Elsevier

Access to resources Recommend Favorite

Rational Antipsychotic Choice: Weighing the Risk of Tardive Dyskinesia and Metabolic Syndrome

By Stoklosa Joseph   Öngür Dost  

Harvard Review of Psychiatry, Vol. 19, Iss. 5, 2011-09 ,pp. : 271-276

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Association analysis of a neural nitric oxide synthase gene polymorphism and antipsychotics-induced tardive dyskinesia in Chinese schizophrenic patients

By Wang Y.-C.   Liou Y.-J.   Liao D.-L.   Bai Y.-M.   Lin C.-C.   Yu S.-C.   Chen J.-Y.  

Journal of Neural Transmission, Vol. 111, Iss. 5, 2004-05 ,pp. : 623-629

Springer Publishing Company

Access to resources Recommend Favorite